InsidersTradesSigma
Track the Lytix Biopharma ASA stock price and the full management transaction log of the company, a listed equity based in Norway. Shares trade on the NO market, under the supervision of Oslo Børs. Operating in the Healthcare & Pharma sector, Lytix Biopharma ASA has logged 18 public disclosures. Market capitalisation: €638.3m. The latest transaction was reported on 3 September 2026 (Option grant). Among the most active insiders: Norwegian Securities Trading Act.. All data is free.
18
Insider Decl.
n/a
Thresholds
€473,332
7 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Lytix Biopharma ASA Strong Buy (bullish), based on 2 analysts. Average price target: NOK 15.00.
17Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
Declarations18 total
OptionMERKOSLO:681627
12,000 shares@ NOK 8.30190.016% mcap100.0% of flowShareMERKOSLO:681499
OptionMERKOSLO:678616
OptionMERKOSLO:670327
ShareMERKOSLO:663387
10,000 shares@ NOK 9.9984100.0% of flowShareMERKOSLO:661716
OptionMERKOSLO:654449
ShareMERKOSLO:635698
ShareMERKOSLO:634985
ShareMERKOSLO:634909
@ €0.0085ShareMERKOSLO:617032
724,448 shares@ NOK 5.24100.0% of flowShareMERKOSLO:616907
OptionMERKOSLO:587883
33,519 shares@ NOK 8.565621.7% of flowShareMERKOSLO:570389
125,000 shares@ NOK 7.971478.3% of flowShareMERKOSLO:569902
13,000 shares@ NOK 7.7274100.0% of flowShareMERKOSLO:569869
18 of 18 declarations
Acerca de Lytix Biopharma ASA
Lytix Biopharma ASA es una empresa biofarmacéutica centrada en el desarrollo de tratamientos inmuno-oncológicos. Cotiza en el mercado XOSL.
